Sofregen Medical, Inc. acquires SERI Surgical Scaffold

On November 11, 2016, Sofregen Medical, Inc. acquired SERI Surgical Scaffold, a life science company in New Jersey, United States, from Allergan plc.

Deal at a glance

AnnouncedNovember 11, 2016 TypeDivestiture TargetSERI Surgical Scaffold Buyer Sofregen Medical, Inc. Seller Allergan plc SectorLife Science LocationNew Jersey, United States ValueNot disclosed

Target company

SERI Surgical Scaffold

New Jersey, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

Sofregen Medical, Inc.

Company · 1 deal on record

1st transaction in life science
1st transaction in United States

1deals, all time

1in this sector

2016latest

Seller

Allergan plc

Company · 10 deals on record

10investments

6in this sector

3exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired SERI Surgical Scaffold?Sofregen Medical, Inc. acquired SERI Surgical Scaffold on November 11, 2016.

Who sold SERI Surgical Scaffold?Allergan plc was the seller.

What type of deal was it?It was a divestiture in the life science sector in 2016.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).